Cargando…
Vaccine safety in an era of novel vaccines: a proposed research agenda
Vaccines have outstanding efficacy and safety records, and the evolving science of vaccines is enabling us to better understand their mechanisms of action as well as the pathways that drive vaccine-related adverse events. This understanding is particularly crucial as novel vaccine antigens, platform...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864453/ https://www.ncbi.nlm.nih.gov/pubmed/35197577 http://dx.doi.org/10.1038/s41577-022-00695-3 |
_version_ | 1784655465151463424 |
---|---|
author | Poland, Gregory A. Kennedy, Richard B. |
author_facet | Poland, Gregory A. Kennedy, Richard B. |
author_sort | Poland, Gregory A. |
collection | PubMed |
description | Vaccines have outstanding efficacy and safety records, and the evolving science of vaccines is enabling us to better understand their mechanisms of action as well as the pathways that drive vaccine-related adverse events. This understanding is particularly crucial as novel vaccine antigens, platforms and adjuvants are increasingly being used. |
format | Online Article Text |
id | pubmed-8864453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-88644532022-02-23 Vaccine safety in an era of novel vaccines: a proposed research agenda Poland, Gregory A. Kennedy, Richard B. Nat Rev Immunol Comment Vaccines have outstanding efficacy and safety records, and the evolving science of vaccines is enabling us to better understand their mechanisms of action as well as the pathways that drive vaccine-related adverse events. This understanding is particularly crucial as novel vaccine antigens, platforms and adjuvants are increasingly being used. Nature Publishing Group UK 2022-02-23 2022 /pmc/articles/PMC8864453/ /pubmed/35197577 http://dx.doi.org/10.1038/s41577-022-00695-3 Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Comment Poland, Gregory A. Kennedy, Richard B. Vaccine safety in an era of novel vaccines: a proposed research agenda |
title | Vaccine safety in an era of novel vaccines: a proposed research agenda |
title_full | Vaccine safety in an era of novel vaccines: a proposed research agenda |
title_fullStr | Vaccine safety in an era of novel vaccines: a proposed research agenda |
title_full_unstemmed | Vaccine safety in an era of novel vaccines: a proposed research agenda |
title_short | Vaccine safety in an era of novel vaccines: a proposed research agenda |
title_sort | vaccine safety in an era of novel vaccines: a proposed research agenda |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864453/ https://www.ncbi.nlm.nih.gov/pubmed/35197577 http://dx.doi.org/10.1038/s41577-022-00695-3 |
work_keys_str_mv | AT polandgregorya vaccinesafetyinaneraofnovelvaccinesaproposedresearchagenda AT kennedyrichardb vaccinesafetyinaneraofnovelvaccinesaproposedresearchagenda |